Drimva

GSK

ViiV Healthcare (GSK) Director/Toxicology Project Specialist

$162K–$297K

USA - Pennsylvania - Upper Providence +3 · Hybrid (Remote & On-site) · Director · Full-time · Posted Sep 16, 2026

Location
USA - Pennsylvania - Upper Providence
USA - Massachusetts - Boston
USA - Connecticut - Branford
USA - North Carolina - Durham
Experience
Master’s degree with 8+ years, or PhD with 6+ years, in non-clinical safety/toxicology.
Education
Master’s degree or PhD

About the job

Develop end-to-end non-clinical safety strategies for ViiV Healthcare projects, integrating toxicology plans with other disciplines and development functions to advance drug development.

What you'll do

  • Lead toxicology project work across 5–10 projects, contributing to safety strategy across discovery and development stages and multiple modalities.
  • Integrate non-clinical safety data into internal decision reviews and regulatory documents, and collaborate with regulatory, clinical, CMC, and other teams.
  • Contribute scientific leadership, external diligence, stakeholder consultation, mentoring, and training.

What they ask for

  • Master’s degree with 8+ years, or PhD with 6+ years, of experience in non-clinical safety/toxicology.
  • Experience as a project team member across multiple projects, development stages, and modalities, including biologics.
  • Non-clinical safety capability and understanding of relationships between disposition, safety, and on/off-target engagement.
  • Knowledge and experience of worldwide regulatory requirements for non-clinical safety in drug development and registration.

Nice to have

  • Experience in non-clinical discovery and development of long-acting small molecules; DABT.
  • Experience in infectious disease therapy, or recognized scientific leadership with an extensive network and publication record.

Pay

$178,200 to $297,000 USD annual base salary (Cambridge, MA; Waltham, MA; Rockville, MD; or San Francisco, CA); $162,000 to $270,000 USD annual base salary (another US location)

Model-written summary · the original posting is authoritative

First seen Oct 28, 2026 · Last verified Nov 6, 2026 (UTC)